Welcome to our dedicated page for Gentex SEC filings (Ticker: GNTX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Gentex Corporation (NASDAQ: GNTX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Gentex is a Michigan-incorporated technology company that supplies digital vision, connected-car, dimmable glass, fire protection, medical, biometric, and consumer electronics products to multiple industries, including automotive and aerospace.
Through this page, users can review current reports on Form 8-K, which Gentex uses to announce material events such as quarterly financial results. For example, the company files 8-K reports to furnish news releases detailing results of operations and financial condition for specific quarters, attaching those releases as exhibits. These documents help investors understand revenue by category, gross margin trends, operating expenses, and the impact of acquisitions like VOXX on consolidated results.
In addition to 8-Ks, investors typically consult annual reports on Form 10-K and quarterly reports on Form 10-Q for more comprehensive information on Gentex’s business, risk factors, segment performance, and capital allocation. Filings related to share repurchases, dividend declarations, and guidance updates can provide further insight into how Gentex manages its balance sheet and returns capital to shareholders.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping users quickly identify major developments, changes in guidance, and important risk disclosures. Real-time updates from EDGAR make it easier to track new Gentex filings as they appear, while access to historical reports supports deeper research into the company’s long-term performance and strategic direction.
Gentex Corp: Schedule 13G/A — The Vanguard Group reports zero beneficial ownership following internal realignment. The filing amends prior disclosures to state that, after an internal realignment effective January 12, 2026, The Vanguard Group and certain subsidiaries will report holdings separately. The Schedule 13G/A shows 0 shares beneficially owned and 0% of the class as reported in the amendment dated 03/13/2026, and is signed on 03/26/2026.
Gentex Corporation files its annual report describing its 2025 operations, strategic acquisitions, and key risks. The company remains focused on automotive rearview mirrors and electronics, which accounted for 89% of consolidated net sales in 2025, while expanding into premium audio, biometrics, and smart home safety.
Gentex completed several deals, including acquiring all of VOXX for $148.3 million, adding automotive electronics, consumer audio brands like Klipsch and Onkyo, and EyeLock iris-biometric technology. It also bought BioConnect and GalvanEyes/BioCenturion to deepen its biometric authentication offerings, and continued rolling out new products such as next‑generation Full Display Mirror, eSightGo low‑vision glasses, and PLACE smart home safety systems.
The company highlights extensive patents and trademarks across its core markets, outlines detailed human capital and inclusivity initiatives for its 6,398 employees as of December 31, 2025, and sets staged greenhouse‑gas reduction and zero‑landfill goals through 2049. Risk factors emphasize auto‑industry cyclicality, tariffs, pricing pressure, supply‑chain constraints, competition in mirrors, audio and biometrics, acquisition integration challenges, and cybersecurity and regulatory compliance.
GENTEX CORP Chief Technology Officer Neil Boehm reported multiple stock transactions involving company common stock. He received a grant of 14,953 shares on February 19, 2026 and a grant of 31,993 performance-based shares on February 17, 2026, both at a stated price of $0.00 per share, reflecting equity awards rather than purchases.
Also on February 17, 2026, shares were withheld to cover tax obligations at $24.89 per share in two transactions totaling 17,768 shares, and he executed open-market sales at $24.82 per share in two transactions totaling 11,248 shares. After these transactions, he directly owned 58,951 shares of Gentex common stock.
GENTEX CORP General Counsel Ryan Scott P reported multiple stock transactions in Gentex common shares. He acquired 11,000 shares on February 19, 2026 and 25,782 shares on February 17, 2026 as grants, both at a stated price of $0.00 per share. The 25,782-share grant is performance-based, with the total tied to long-term incentives and vesting 100% three years from the grant date.
On February 17, 2026, he disposed of shares to cover tax obligations, delivering 11,492 shares and 2,907 shares at $24.89 per share. He also executed open-market sales of 7,145 shares and 1,879 shares at an average price of $24.7302 per share, totaling 9,024 shares sold. After these transactions, he directly owned 44,279 Gentex shares.
Gentex Corp Chief Financial Officer Kevin C. Nash reported multiple stock transactions involving common shares. He acquired 13,880 shares on February 19, 2026 as a grant at no cost, increasing his holdings in that transaction to 73,310 shares.
On February 17, 2026, he received an additional grant of 38,181 performance-based shares, with the total number tied to long-term performance incentives and vesting 100% three years from the grant award date. The Form 4 also shows tax-withholding dispositions totaling 16,864 and 4,306 shares at $24.8900 per share, and open-market sales of 6,317 and 5,568 shares at $24.9767 per share.
After these transactions, Nash directly owned 59,430 common shares of Gentex Corp.
Gentex Corporation President and CEO Steven R. Downing reported multiple stock transactions involving company common shares. He received two equity awards, acquiring 43,492 shares on February 19, 2026 and 124,311 performance-based shares on February 17, 2026, both at a stated price of $0.00 per share.
The 124,311 performance-based shares were granted under long-term performance incentives and vest 100% three years from the grant award date. On February 17, 2026, shares were also disposed of to cover tax obligations, with 54,314 and 14,018 shares withheld at $24.89 per share, and 35,000 shares sold in an open-market transaction at an average price of $24.7457 per share. Following these transactions, Downing directly owned 211,670 Gentex common shares.
Gentex Corporation vice president of sales Matthew Chiodo reported a mix of stock awards, tax-related share dispositions, and open-market sales of common stock. On February 17, he received a grant of 28,269 performance-based shares, with the number tied to long-term performance incentives and vesting 100% three years from the grant date. That same day, Form 4 data shows tax-withholding dispositions of shares at about $24.89 per share and open-market sales totaling 19,827 shares at about $25.03 per share. On February 19, he received an additional award of 12,047 shares of common stock, bringing his directly held stake to 47,148 shares after the reported transactions.
A Rule 144 notice discloses a planned sale of 11,885 shares of common stock, with an aggregate market value of 296,848.08, through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ exchange around 02/17/2026.
The shares come from recent equity compensation: 6,317 shares acquired on 02/16/2026 via performance stock units and 5,568 shares from restricted stock vesting under a registered plan, both for services rendered. The seller represents they are not aware of any undisclosed material adverse information about the issuer.
A security holder of GNTX filed a Form 144 notice to potentially sell 35,000 shares of common stock through Morgan Stanley Smith Barney LLC on 02/17/2026, with an aggregate market value of $866,099.50. The filing notes that these 35,000 shares were acquired on 02/16/2026 as Performance Stock Units for services rendered. The notice also reports that 218,942,919 shares of this class were outstanding at the time, providing context for the size of the planned sale.
Gentex Corporation had an affiliated holder give notice of intent to sell up to 19,827 shares of its common stock under Rule 144. The planned sale, through Morgan Stanley Smith Barney LLC, has an aggregate market value of 496,170.68 and is listed for NASDAQ.
The shares come from recent equity compensation awards. On 02/16/2026, the seller acquired 15,705 shares via performance stock units and 4,122 shares from restricted stock vesting under a registered plan, both described as payment for services rendered.